Rituximab decreases without preference all subclasses of IgG anti-BP180 autoantibodies in refractory bullous pemphigoid (BP).

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Ronaghy, A; Streilein, RD; Hall, RP

Published Date

  • April 2014

Published In

Volume / Issue

  • 74 / 1

Start / End Page

  • 93 - 94

PubMed ID

  • 24461673

Pubmed Central ID

  • 24461673

Electronic International Standard Serial Number (EISSN)

  • 1873-569X

Digital Object Identifier (DOI)

  • 10.1016/j.jdermsci.2013.11.014

Language

  • eng

Conference Location

  • Netherlands